Is PRP FDA approved?

What exactly did the FDA clear?

The distinction that trips up marketing copy is between the device and the procedure. PRP preparation systems — the centrifuge, the separation tube, the anticoagulant and the disposable kit — are regulated as medical devices, and many have received 510(k) clearance. A 510(k) clearance means the manufacturer demonstrated the device is substantially equivalent to a legally marketed predicate device; it is a comparison, not a finding of clinical efficacy.

Clearance summaries for PRP systems commonly carry an explicit indication limited to preparing platelet-rich plasma from a small sample of blood, often qualified for use at the point of care and for mixing with bone graft material, and several state directly that the PRP produced has not been evaluated for, and is not indicated for, any specific clinical use. The FDA has approved no PRP product for treating androgenetic alopecia, facial rejuvenation, skin quality or the procedures marketed as a "vampire facial."

So three different statements are true at once, and only one of them is marketable: the device is FDA cleared; the procedure is not FDA approved; using it aesthetically is off-label practice of medicine, which is lawful.

Why does the wording matter legally?

Two exposures follow from getting it wrong. The first is consumer protection. The Federal Trade Commission polices health claims in advertising under a substantiation standard, and state consumer protection statutes give private plaintiffs and attorneys general a route to challenge claims that a treatment is FDA approved when it is not. "FDA approved" is one of the most commonly cited misrepresentations in aesthetic advertising enforcement.

The second is informed consent. If a patient can testify they chose the treatment because they were told it was FDA approved, the consent is undermined regardless of technique. Aesthetic PRP has limited and heterogeneous evidence — that is a legitimate thing to offer and an illegitimate thing to overstate.

There is also a manufacturing dimension. FDA treats human cells, tissues and cellular and tissue-based products under a framework where minimal manipulation and homologous use keep a preparation outside the drug and biologic approval pathways. Standard autologous PRP prepared and reinjected in one sitting is generally treated as within the practice of medicine. Expanding, culturing, adding growth factors or combining PRP with other substances can push a preparation toward being regulated as a biologic drug requiring approval — a distinction worth legal review before you launch a proprietary variant.

How should a clinic describe PRP publicly?

Say what is true and specific: PRP uses the patient's own blood, processed in an FDA-cleared system, and is used off-label for aesthetic and hair indications; published results are mixed and individual response varies; multiple sessions are typically required with maintenance thereafter. Avoid "approved," "proven," "guaranteed," and before-and-after galleries presented without disclosure that results are not typical.

What this means for your paperwork

Your PRP consent should carry an FDA status paragraph in plain language, stating that the preparation device is cleared, that the procedure is not FDA approved for this indication, and that the use is off-label. Have the patient initial it separately.

Keep the 510(k) number and manufacturer documentation for the kit you actually use on file, and keep kit lot numbers in the chart. Audit your website, social media, intake packet and staff consultation script against the consent language at least annually — the most common finding is a website promising FDA-approved treatment while the consent correctly says the opposite, which proves the patient received two contradictory messages and chose based on the louder one.

Related questions